Product/Composition:- | Acarbose Oral Tablets |
---|---|
Strength:- | 25 mg, 50 mg, 100 mg |
Form:- | Tablets |
Reference Brands:- | Precose® (USA), Glucobay® (EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Acarbose inhibits alpha-glucosidase enzymes in the small intestine, delaying carbohydrate digestion and glucose absorption. This action helps prevent postprandial blood sugar spikes, supporting better glycemic control in type 2 diabetes. It works independently of insulin secretion, making it effective when used alone or with other antidiabetic medications.
Acarbose tablets are approved in the USA by the FDA under the brand name Precose® and are indicated for managing type 2 diabetes mellitus. In the EU, acarbose is marketed under names like Glucobay® and is authorized through national procedures, particularly in countries such as Germany, the UK, and Spain. It is available as a prescription-only medication. Acarbose must meet the EMA’s quality and safety standards, with generics also widely available. As a carbohydrate absorption inhibitor, it complements other oral antidiabetics. For trusted suppliers and compliant sourcing, visit Pharmatradz.com.